Intelligent Net Receivables vs Net Debt Analysis
| INBS Stock | USD 2.38 0.04 1.71% |
Intelligent Bio financial indicator trend analysis is infinitely more than just investigating Intelligent Bio Solutions recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Intelligent Bio Solutions is a good investment. Please check the relationship between Intelligent Bio Net Receivables and its Net Debt accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Intelligent Bio Solutions. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Net Receivables vs Net Debt
Net Receivables vs Net Debt Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Intelligent Bio Solutions Net Receivables account and Net Debt. At this time, the significance of the direction appears to have pay attention.
The correlation between Intelligent Bio's Net Receivables and Net Debt is -0.98. Overlapping area represents the amount of variation of Net Receivables that can explain the historical movement of Net Debt in the same time period over historical financial statements of Intelligent Bio Solutions, assuming nothing else is changed. The correlation between historical values of Intelligent Bio's Net Receivables and Net Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Receivables of Intelligent Bio Solutions are associated (or correlated) with its Net Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Debt has no effect on the direction of Net Receivables i.e., Intelligent Bio's Net Receivables and Net Debt go up and down completely randomly.
Correlation Coefficient | -0.98 |
| Relationship Direction | Negative |
| Relationship Strength | Significant |
Net Receivables
Net Debt
The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.Most indicators from Intelligent Bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Intelligent Bio Solutions current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Intelligent Bio Solutions. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Selling General Administrative is likely to drop to about 4 M in 2024. Issuance Of Capital Stock is likely to drop to about 2.4 M in 2024
Intelligent Bio fundamental ratios Correlations
Click cells to compare fundamentals
Intelligent Bio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Intelligent Bio fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 2.3M | 2.5M | 20.4M | 12.4M | 14.2M | 8.3M | |
| Short Long Term Debt Total | 4.8M | 5.1M | 5.1M | 1.3M | 1.2M | 1.1M | |
| Other Current Liab | 2.1M | (21.8K) | 1.1M | 201.3K | 181.2K | 172.1K | |
| Total Current Liabilities | 6.3M | 7.7M | 3.7M | 4.7M | 4.2M | 4.5M | |
| Total Stockholder Equity | (4.6M) | (5.2M) | 13.6M | 6.6M | 7.6M | 8.0M | |
| Net Debt | 4.9M | 4.7M | (12.6M) | (8.2M) | (7.4M) | (7.0M) | |
| Retained Earnings | (12.7M) | (15.8M) | (24.3M) | (31.2M) | (28.1M) | (26.7M) | |
| Accounts Payable | 483.6K | 1.5M | 715.9K | 1.6M | 1.9M | 2.0M | |
| Cash | 197.9K | 427.3K | 12.6M | 8.2M | 9.5M | 4.7M | |
| Cash And Short Term Investments | 197.9K | 427.3K | 12.6M | 8.2M | 9.5M | 4.7M | |
| Liabilities And Stockholders Equity | 2.5M | 20.4M | 12.4M | 12.4M | 14.2M | 8.4M | |
| Non Current Liabilities Total | 6.0M | 5.6M | 3.2M | 1.1M | 1.0M | 977.6K | |
| Other Current Assets | 12.1K | 3.8M | 163.1K | 746.8K | 858.8K | 850.3K | |
| Other Stockholder Equity | (8.7M) | (9.2M) | 38.4M | 38.4M | 44.2M | 46.4M | |
| Total Liab | 6.3M | 7.7M | 6.9M | 5.8M | 5.2M | 5.1M | |
| Total Current Assets | 2.3M | 2.3M | 16.4M | 10.9M | 12.5M | 7.2M | |
| Accumulated Other Comprehensive Income | (216.9K) | (364.0K) | (661.3K) | (788.1K) | (709.3K) | (673.9K) | |
| Short Term Debt | 5.1M | 5.1M | 137.8K | 576.7K | 519.0K | 493.0K | |
| Common Stock | 2.0M | 2.9M | 142.3K | 148.9K | 134.0K | 127.3K | |
| Net Receivables | 19.6K | 3.2M | 2.5M | 1.9M | 2.2M | 1.4M | |
| Inventory | 1.9M | (3.2M) | 0.0 | 1.0 | 0.9 | 0.86 | |
| Net Tangible Assets | (5.2M) | 15.0M | 6.6M | (1.5M) | (1.7M) | (1.8M) | |
| Net Invested Capital | (17.4M) | 15.0M | 6.6M | 4.6M | 5.2M | 5.5M | |
| Capital Stock | 20.2M | 148.8K | 148.9K | 23.3K | 21.0K | 19.9K | |
| Net Working Capital | (5.4M) | 14.5M | 6.2M | (2.0M) | (2.3M) | (2.2M) |
Pair Trading with Intelligent Bio
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Intelligent Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intelligent Bio will appreciate offsetting losses from the drop in the long position's value.Moving together with Intelligent Stock
| 0.9 | DOCS | Doximity Financial Report 21st of May 2024 | PairCorr |
| 0.81 | VEEV | Veeva Systems Class Financial Report 29th of May 2024 | PairCorr |
| 0.79 | ENSG | Ensign Group | PairCorr |
Moving against Intelligent Stock
| 0.86 | HAE | Haemonetics | PairCorr |
| 0.85 | EHC | Encompass Health Corp | PairCorr |
| 0.79 | ELV | Elevance Health Financial Report 17th of July 2024 | PairCorr |
| 0.41 | DVA | DaVita HealthCare | PairCorr |
The ability to find closely correlated positions to Intelligent Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Intelligent Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Intelligent Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Intelligent Bio Solutions to buy it.
The correlation of Intelligent Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Intelligent Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Intelligent Bio Solutions moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Intelligent Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Intelligent Bio Solutions. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Intelligent Bio Solutions information on this page should be used as a complementary analysis to other Intelligent Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Complementary Tools for Intelligent Stock analysis
When running Intelligent Bio's price analysis, check to measure Intelligent Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intelligent Bio is operating at the current time. Most of Intelligent Bio's value examination focuses on studying past and present price action to predict the probability of Intelligent Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intelligent Bio's price. Additionally, you may evaluate how the addition of Intelligent Bio to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |
Is Intelligent Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Intelligent Bio. If investors know Intelligent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Intelligent Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (29.56) | Revenue Per Share 3.292 | Quarterly Revenue Growth 0.802 | Return On Assets (0.46) | Return On Equity (1.19) |
The market value of Intelligent Bio Solutions is measured differently than its book value, which is the value of Intelligent that is recorded on the company's balance sheet. Investors also form their own opinion of Intelligent Bio's value that differs from its market value or its book value, called intrinsic value, which is Intelligent Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Intelligent Bio's market value can be influenced by many factors that don't directly affect Intelligent Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Intelligent Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Intelligent Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Intelligent Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.